Related Experiment Video
Updated: Aug 15, 2026

A Comprehensive Approach to Analyze the Cell Components of Cerebral Blood Clots
Published on: July 21, 2023
Update in thrombosis: answers to perplexing questions
Daniel G Federman1, Gina R Brescia, John P Moriarty
1Department of Medicine, Section of General Medicine, Firm Chief, VA Connecticut Health Care System, West Haven, CT, USA. daniel.federman@med.va.gov
Abstract:
Recent clinical trials are answering some of the perplexing clinical questions about venous thromboembolism (VTE), such as the length and intensity of anticoagulation needed to prevent recurrence. We review some of these clinical trials and their implications for physicians and patients.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Clot Retraction and Fibrinolysis
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

